fda approved indications for tirzepatide Back to routine postings! Here's a high level overview of tirzepatide. 💊 is a dual GIP/GLP-1 receptor agonists. GIP & GLP-1 are both incretins, so some refer to this drug as Tirzepatide for Losing Weight: Mechanism

Tirzepatide is a dual-acting medication known as a GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist

For people with obesity who are concerned with Alzheimers risk, would it be a good option to consider Ozempic or Wegovy to help reduce that risk

At its July 23-24, 2026 meeting, the FDAs Pharmacy Compounding Advisory Committee reviews seven peptides for 503A eligibility: on July 23, BPC-157, KPV, TB-500, and MOTS-C

Treatment of L-serine also significantly downregulated 195 genes and upregulated 136 genes in the IL7R low naive CD4 T cell subtype of the patients (Supplementary Data 2)